icon-folder.gif   Conference Reports for NATAP  
  65th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 7-11 2014
Back grey_arrow_rt.gif
Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin for the Treatment of Patients With Chronic HCV Genotype 1 Infection:
An Analysis of the Phase 3 ION Trials

  Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
Saleh Alqahtani,1 NezamAfdhal,2 Stefan Zeuzem,3 Stuart Gordon,4 Alessandra Mangia,5 Paul Kwo,6 Jenny C. Yang,7 Xiao Ding,7 Phillip S. Pang,7 John G. McHutchison,7 Patrick Marcellin,8 Kris Kowdley,9 Mark Sulkowski1 1Johns Hopkins Medical Center, Baltimore, MD; 2Beth Israel Deaconess Medical Center, Boston, MA; 3Johann Wolfgang Goethe University, Frankfurt, Germany; 4Henry Ford Health System, Detroit, MI; 5Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy;
6Indiana University School of Medicine, Indianapolis, IN; 7Gilead Sciences, Inc., Foster City, CA; 8Centre Hospitalier Universitaire Beaujon, Clichy-sous-Bois, France; 9Virginia Mason Medical Center, Seattle, WA